摘要
表观遗传学是指由于修饰DNA结构的核苷酸的生化改变而导致的基因表达的改变,而不是由于基因密码子所引起的改变。表观基因,包括染色质和它的变型体,其作为继承的基因组中链接环境所施加的变化。在过去的十年中,出现了越来越多的证据暗示表观遗传修饰和各种人为条件,如老化,这个人类最常见的疾病。癌症,心血管疾病、糖尿病、类风湿关节炎、艾滋病毒等,这些都以最明确的证据作为中心机制的共同多因素疾病,已被确定与炎症反应有关。牙周疾病,基本上是免疫炎症的问题,是一个多因素的复杂疾病,由于它的高发病率,慢性和广泛的全身效应,本质上来说可以更好的理解基础疾病的机制,以开发和破译一种新颖的方法来对付这种疾病。本文的目的是可视牙周病从表观遗传学角度来看,具有当代的支持证据文献和趋向,探讨可能找到一些解释牙周全身健康链接,个性化的和简易的诊断工具,为了早期发现以及如何停止疾病和基于生物学的方法帮助再生和重建丢失牙周附着组织。
关键词: 慢性炎症,表观遗传学,免疫细胞,个体化治疗,微生物感染,牙周疾病。
Current Gene Therapy
Title:Epigenetics and Periodontal Disease: Hope to Tame the Untameable
Volume: 14 Issue: 6
Author(s): Vishakha Grover, Anoop Kapoor, Ranjan Malhotra and Sonia Sachdeva
Affiliation:
关键词: 慢性炎症,表观遗传学,免疫细胞,个体化治疗,微生物感染,牙周疾病。
摘要: Epigenetics means gene expression alterations which occur due to the biochemical changes of the nucleotides modifying structure of DNA rather than the changes in the genetic code itself as in case of mutations. The epigenome, consisting of chromatin and its modifications, acts as a link between the inherited genome and the changes imposed by the environment. Over the past decade, there has been mounting evidence suggestive of associations between epigenetic modifications and various human conditions such as aging, and most common human diseases viz. cancer, cardiovascular diseases, diabetes, rheumatoid arthritis, HIV etc and the clearest evidence as the central mechanism for common multifactorial diseases, has been identified with the factors involved in the inflammatory response. Periodontal disease, basically an immune-inflammatory affliction, being a multifactorial complex disease, owing to its high prevalence, chronicity and wide ranging systemic effects, essentially calls for a better comprehension of the underlying disease mechanisms, so as to develop and decipher the novel methodologies to combat this disease. The current paper aims to visualize periodontal disease from an epigenetic perspective, featuring the contemporary evidence supported literature and tends to explore the possibilities to find some explanations for perio-systemic health links, individualized and improvised diagnostic tools for earlier detection and ways to halt the disease and help regeneration and reconstruction of the lost periodontal attachment apparatus with the biology based approaches.
Export Options
About this article
Cite this article as:
Grover Vishakha, Kapoor Anoop, Malhotra Ranjan and Sachdeva Sonia, Epigenetics and Periodontal Disease: Hope to Tame the Untameable, Current Gene Therapy 2014; 14 (6) . https://dx.doi.org/10.2174/1566523214666140918103313
DOI https://dx.doi.org/10.2174/1566523214666140918103313 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Potential of Non-Coding RNAs and TLR Signalling Pathways in Rheumatoid Arthritis
Current Pharmaceutical Biotechnology STAT3: A Molecular Target for Cancer Whose Time Has Come
Current Signal Transduction Therapy Novel Epigenetic Targets in Lymphoproliferative Disorders
Current Cancer Drug Targets Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents
Current Drug Targets Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Visfatin/PBEF and Atherosclerosis-Related Diseases
Current Vascular Pharmacology Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders-Drug Targets Gene Expression Profiling as a Tool for Positional Cloning of Genes- Shortcut or the Longest Way Round
Current Genomics Tuftsin – Properties and Analogs
Current Medicinal Chemistry An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Anti-TNF Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases
Current Pharmaceutical Design Beyond the Reproductive Effect of Sex Steroids: Their Role During Immunity to Helminth Parasite Infections
Mini-Reviews in Medicinal Chemistry Editorial [Immunogenicity of Biotherapeutics: A Need for Consensus on Flexibility of Approach (Guest Editor: Stewart Barker)]
Current Drug Safety Cofactor Mimics as Selective Inhibitors of NAD-dependent Inosine Monophospate Dehydrogenase (IMPDH) - the Major Therapeutic Target
Current Medicinal Chemistry Profiling the Shear Stress of Atherosclerosis; A Genomic View
Current Genomics Novel Interpenetrating Polymer Matrix Network Microparticles for Intestinal Drug Delivery
Current Drug Delivery The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?
Current Pharmaceutical Design